(Q45873592)

English

Early prophylaxis/FVIII tolerization regimen that avoids immunological danger signals is still effective in minimizing FVIII inhibitor developments in previously untreated patients--long-term follow-up and continuing experience

scientific article published on 27 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21951822

Early prophylaxis/FVIII tolerization regimen that avoids immunological danger signals is still effective in minimizing FVIII inhibitor developments in previously untreated patients--long-term follow-up and continuing experience (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21951822

1 reference

based on heuristic

inferred from title

Christoph Bidlingmaier

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21951822

author name string

G Auerswald

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21951822

K Kurnik

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21951822

language of work or name

1 reference

based on heuristic

inferred from title

publication date

27 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21951822

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21951822

18

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21951822

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21951822

e18-20

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21951822

Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02659.X

21 January 2018

A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02659.X

21 January 2018

Haemophilia care in children--benefits of early prophylaxis for inhibitor prevention

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02659.X

21 January 2018

The multifactorial etiology of inhibitor development in hemophilia: genetics and environment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02659.X

21 January 2018

Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02659.X

21 January 2018

New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02659.X

21 January 2018

Identifiers

10.1111/J.1365-2516.2011.02659.X

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21951822

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21951822

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45873592&oldid=2087783847"